ID

39570

Beschreibung

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT02366208

Link

https://clinicaltrials.gov/show/NCT02366208

Stichworte

  1. 30.01.20 30.01.20 -
  2. 30.01.20 30.01.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

30. Januar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis B, Chronic NCT02366208

Eligibility Hepatitis B, Chronic NCT02366208

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hepatitis b for more than 6 months
Beschreibung

Chronic Hepatitis B Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0524909
UMLS CUI [1,2]
C0872146
alt > 2 × upper limit normal (uln)
Beschreibung

Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0151905
serum bilirubin < 2 × uln.
Beschreibung

Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
positive hbeag and hbv-dna between 1.00e+05 iu/ml and 9.99e+09 iu/ml.
Beschreibung

Hepatitis B e antigen positive | Hepatitis B DNA Measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0392390
UMLS CUI [2]
C3641250
informed consent form (icf) signed.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
hepatitis a,c,d,e or hiv infection.
Beschreibung

Hepatitis A | Hepatitis C | Hepatitis D Infection | Hepatitis E | HIV Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0019159
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0011226
UMLS CUI [4]
C0085293
UMLS CUI [5]
C0019693
autoimmune hepatitis.
Beschreibung

Hepatitis, Autoimmune

Datentyp

boolean

Alias
UMLS CUI [1]
C0241910
hepatic cirrhosis.
Beschreibung

Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
serum creatinine > 1.5 × uln or ccr < 50 ml/min, haemoglobin < 110g/l (male) or <
Beschreibung

Serum creatinine raised | Creatinine clearance measurement | Hemoglobin measurement | Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0700225
UMLS CUI [2]
C0373595
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0079399
100g/l (female), platelet< 80 e+09/l, serum albumin ≤ 32g/l, or serum albumin/globulin (a/g) ≤0.9, neutrophile granulocyte < 1.0 e+09/l, prothrombin time>uln+3 seconds, cholinesterase<2500u/l.
Beschreibung

Platelet Count measurement | Serum albumin measurement | Albumin to Globulin Ratio Measurement | Neutrophil count | Prothrombin time assay | Cholinesterase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0523465
UMLS CUI [3]
C2697980
UMLS CUI [4]
C0200633
UMLS CUI [5]
C0033707
UMLS CUI [6]
C0202207
hepatitic carcinoma or alpha fetal protein (afp) > 100ng/ml
Beschreibung

Other Coding | Alpha one fetoprotein measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3846158
UMLS CUI [2]
C0201539
patients with other severe diseases combined, which could affect the therapy.
Beschreibung

Comorbidity Severe Affecting Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C0087111
patients accepted other clinical trial within 6 months before the first administrated.
Beschreibung

Study Subject Participation Status | Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
patients accepted immunomodulating or anti-viral treatment within 6 months before the trial.
Beschreibung

Immunomodulatory therapy | Antiviral Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1963758
UMLS CUI [2]
C0280274
patients with autoimmune disease.
Beschreibung

Autoimmune Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0004364
thymosin allergy.
Beschreibung

Hypersensitivity Thymosin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0040106
pregnant or breast feeding.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Ähnliche Modelle

Eligibility Hepatitis B, Chronic NCT02366208

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis B Disease length
Item
chronic hepatitis b for more than 6 months
boolean
C0524909 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Alanine aminotransferase increased
Item
alt > 2 × upper limit normal (uln)
boolean
C0151905 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin < 2 × uln.
boolean
C1278039 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B DNA Measurement
Item
positive hbeag and hbv-dna between 1.00e+05 iu/ml and 9.99e+09 iu/ml.
boolean
C0392390 (UMLS CUI [1])
C3641250 (UMLS CUI [2])
Informed Consent
Item
informed consent form (icf) signed.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hepatitis A | Hepatitis C | Hepatitis D Infection | Hepatitis E | HIV Infection
Item
hepatitis a,c,d,e or hiv infection.
boolean
C0019159 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0011226 (UMLS CUI [3])
C0085293 (UMLS CUI [4])
C0019693 (UMLS CUI [5])
Hepatitis, Autoimmune
Item
autoimmune hepatitis.
boolean
C0241910 (UMLS CUI [1])
Liver Cirrhosis
Item
hepatic cirrhosis.
boolean
C0023890 (UMLS CUI [1])
Serum creatinine raised | Creatinine clearance measurement | Hemoglobin measurement | Gender
Item
serum creatinine > 1.5 × uln or ccr < 50 ml/min, haemoglobin < 110g/l (male) or <
boolean
C0700225 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0079399 (UMLS CUI [4])
Platelet Count measurement | Serum albumin measurement | Albumin to Globulin Ratio Measurement | Neutrophil count | Prothrombin time assay | Cholinesterase measurement
Item
100g/l (female), platelet< 80 e+09/l, serum albumin ≤ 32g/l, or serum albumin/globulin (a/g) ≤0.9, neutrophile granulocyte < 1.0 e+09/l, prothrombin time>uln+3 seconds, cholinesterase<2500u/l.
boolean
C0032181 (UMLS CUI [1])
C0523465 (UMLS CUI [2])
C2697980 (UMLS CUI [3])
C0200633 (UMLS CUI [4])
C0033707 (UMLS CUI [5])
C0202207 (UMLS CUI [6])
Other Coding | Alpha one fetoprotein measurement
Item
hepatitic carcinoma or alpha fetal protein (afp) > 100ng/ml
boolean
C3846158 (UMLS CUI [1])
C0201539 (UMLS CUI [2])
Comorbidity Severe Affecting Therapy
Item
patients with other severe diseases combined, which could affect the therapy.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Study Subject Participation Status | Clinical Trial
Item
patients accepted other clinical trial within 6 months before the first administrated.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
Immunomodulatory therapy | Antiviral Therapy
Item
patients accepted immunomodulating or anti-viral treatment within 6 months before the trial.
boolean
C1963758 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Autoimmune Disease
Item
patients with autoimmune disease.
boolean
C0004364 (UMLS CUI [1])
Hypersensitivity Thymosin
Item
thymosin allergy.
boolean
C0020517 (UMLS CUI [1,1])
C0040106 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video